| Motif ID |
Motif Logo |
Scanned Score Distribution |
Frequency of Motif |
Replicability Score |
Evolutionary Conservation Score |
Gene Targets |
Gene Ontology of CpGMM targets |
| CG_ffipsc1911_promoter_p_RM_12_284_7 |
 |
 |
5 |
1.0 |
3.18E-04 |
ARPC2,
WNT1,
PLOD1,
RGS6,
WIPF2,
MAVS,
NLRX1,
CRHR1,
CCND1 |
protein binding [MF],
negative regulation of type I interferon production [BP],
positive regulation of IP-10 production [BP],
midbrain-hindbrain boundary maturation during brain development [BP],
organ regeneration [BP],
cerebellum formation [BP],
hydroxylysine biosynthetic process [BP],
canonical Wnt receptor signaling pathway [BP],
negative regulation of DNA damage checkpoint [BP] |
| CG_ffipsc1911_promoter_p_RM_14_22_2 |
 |
 |
5 |
0.8 |
2.11E-04 |
SPTBN4,
ARPC2 |
axon hillock [CC],
Arp2/3 complex binding [MF],
cell body fiber [CC],
structural constituent of cytoskeleton [MF],
actin cytoskeleton [CC],
AP-1 adaptor complex binding [MF],
cell leading edge [CC] |
| CG_ffipsc1911_promoter_p_RM_12_148_7 |
 |
 |
6 |
1.0 |
2.50E-04 |
ZNF143,
AR,
PEX3,
PEX26,
CCND1 |
regulation of transcription from RNA polymerase III promoter [BP],
integral to peroxisomal membrane [CC],
protein import into peroxisome membrane [BP],
mammary gland alveolus development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_18_10 |
 |
 |
5 |
0.8 |
2.69E-04 |
KLC3 |
cardiolipin synthase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_14_17_2 |
 |
 |
7 |
1.0 |
6.96E-04 |
SOX11 |
positive regulation of lens epithelial cell proliferation [BP],
regulation of transforming growth factor beta receptor signaling pathway [BP],
closure of optic fissure [BP],
positive regulation of hippo signaling cascade [BP] |
| CG_ffipsc1911_promoter_p_RM_12_87_5 |
 |
 |
3 |
0.6 |
1.24E-04 |
PLOD1,
PNMT,
IVD |
hydroxylysine biosynthetic process [BP],
isovaleryl-CoA dehydrogenase activity [MF],
phenylethanolamine N-methyltransferase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_96_2 |
 |
 |
2 |
0.4 |
3.90E-04 |
FEM1A |
EP4 subtype prostaglandin E2 receptor binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_137_4 |
 |
 |
4 |
0.8 |
4.46E-04 |
TPM1,
ALDH5A1 |
succinate-semialdehyde dehydrogenase (NAD+) activity [MF],
positive regulation of heart rate by epinephrine [BP],
succinate-semialdehyde dehydrogenase [NAD(P)+] activity [MF] |
| CG_ffipsc1911_promoter_p_RM_14_30_2 |
 |
 |
5 |
0.6 |
4.21E-04 |
B3GALT4 |
ganglioside galactosyltransferase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_104_4 |
 |
 |
3 |
0.6 |
5.33E-04 |
VCL,
PFAS,
SHROOM2 |
eye pigment granule organization [BP],
beta-catenin binding [MF],
cell-cell adherens junction [CC],
phosphoribosylformylglycinamidine synthase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_269_8 |
 |
 |
2 |
0.4 |
2.76E-04 |
BCL2L11,
GABRA5 |
cellular process regulating host cell cycle in response to virus [BP],
neuronal cell body membrane [CC],
BIM-BCL-2 complex [CC],
BIM-BCL-xl complex [CC] |
| CG_ffipsc1911_promoter_p_RM_12_85_11 |
 |
 |
3 |
0.6 |
2.37E-04 |
ACADVL |
acyl-CoA dehydrogenase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_80_9 |
 |
 |
5 |
0.8 |
2.77E-04 |
GATA4,
PROX1,
ARHGEF10 |
ventricular cardiac muscle tissue development [BP],
cardiac ventricle morphogenesis [BP],
positive regulation of GTP catabolic process [BP],
DBD domain binding [MF],
positive regulation of G1/S transition checkpoint [BP],
positive regulation of forebrain neuron differentiation [BP],
epithelial cell fate commitment [BP],
lung lobe formation [BP],
ventricular septum development [BP],
hepatocyte cell migration [BP],
cardiac muscle cell differentiation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_135_4 |
 |
 |
4 |
0.6 |
1.73E-04 |
B3GALT6 |
galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_236_5 |
 |
 |
3 |
0.6 |
9.20E-05 |
NTRK1 |
neurotrophin p75 receptor binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_94_7 |
 |
 |
5 |
1.0 |
2.56E-04 |
ITGB8,
S1PR1,
PKP4,
FOXF1,
CDH3,
COL15A1 |
blood vessel development [BP],
cell adhesion [BP] |
| CG_ffipsc1911_promoter_p_RM_14_27_5 |
 |
 |
4 |
0.6 |
3.59E-04 |
SNX9,
RBM4,
NT5M,
DUT |
dUTP diphosphatase activity [MF],
circadian regulation of translation [BP],
IRES-dependent translational initiation [BP],
cap-independent translational initiation [BP],
dUMP catabolic process [BP],
lipid tube assembly [BP],
pre-mRNA intronic pyrimidine-rich binding [MF],
pyrimidine nucleobase metabolic process [BP],
dUMP biosynthetic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_1_3 |
 |
 |
5 |
1.0 |
4.43E-04 |
GRHL3,
RAC1 |
Wnt receptor signaling pathway, planar cell polarity pathway [BP],
establishment of planar polarity [BP],
cochlea morphogenesis [BP] |
| CG_ffipsc1911_promoter_p_RM_12_232_4 |
 |
 |
4 |
0.8 |
3.89E-04 |
RPS27A,
INSM2,
NR2F2,
NFYA,
BMPR2,
ZNF778,
SOX2,
PDPK1,
HTRA3,
SP4 |
negative regulation of transforming growth factor beta receptor signaling pathway [BP],
transcription from RNA polymerase II promoter [BP],
regulation of transcription, DNA-dependent [BP],
regulation of endothelial cell migration [BP],
lymphatic endothelial cell differentiation [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_ffipsc1911_promoter_p_RM_12_54_8 |
 |
 |
4 |
0.6 |
3.84E-04 |
CHAMP1 |
attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation [BP],
sister chromatid biorientation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_66_2 |
 |
 |
4 |
0.8 |
1.82E-04 |
GATA3,
VIL1 |
cytoplasmic actin-based contraction involved in cell motility [BP],
lysophosphatidic acid binding [MF],
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP],
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP],
negative regulation of cell proliferation involved in mesonephros development [BP],
regulation of histone H3-K27 methylation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_219_11 |
 |
 |
4 |
0.8 |
2.94E-04 |
CHD7,
ZNF354B,
TIGD5,
NPAS1,
WRNIP1,
ZNF574,
TAF15,
PAPD5,
G3BP1,
GATAD2A,
OVOL1 |
DNA binding [MF],
neural fold formation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_205_7 |
 |
 |
6 |
0.6 |
2.35E-04 |
ABCG1,
CD38,
FOXQ1,
ISL1,
ITGAV,
IL17RB,
WNT3A |
negative regulation of lipid storage [BP],
cell surface [CC],
negative regulation of macrophage derived foam cell differentiation [BP],
estrogen receptor binding [MF],
positive regulation of cell adhesion [BP] |
| CG_ffipsc1911_promoter_p_RM_14_13_2 |
 |
 |
4 |
0.4 |
2.66E-04 |
SPCS1,
ACAD8 |
valine catabolic process [BP],
signal peptidase complex [CC] |
| CG_ffipsc1911_promoter_p_RM_12_9_5 |
 |
 |
2 |
0.4 |
1.55E-04 |
COL1A2,
NR2E1,
TSKU |
amygdala development [BP],
collagen type I [CC],
anterior commissure morphogenesis [BP] |
| CG_ffipsc1911_promoter_p_RM_14_29_7 |
 |
 |
5 |
0.8 |
8.92E-05 |
NQO2 |
dihydronicotinamide riboside quinone reductase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_64_4 |
 |
 |
4 |
0.8 |
3.14E-04 |
VANGL2,
HSPA6,
GPS1,
APC,
KIRREL |
negative regulation of protein phosphorylation [BP],
negative regulation of MAPK cascade [BP],
lateral plasma membrane [CC],
signalosome [CC] |
| CG_ffipsc1911_promoter_p_RM_12_7_4 |
 |
 |
6 |
1.0 |
1.91E-04 |
TBC1D10C |
intracellular [CC] |
| CG_ffipsc1911_promoter_p_RM_14_15_2 |
 |
 |
4 |
0.4 |
2.23E-04 |
DFFB,
PRKCD |
positive regulation of sphingomyelin catabolic process [BP],
positive regulation of glucosylceramide catabolic process [BP],
positive regulation of phospholipid scramblase activity [BP],
cellular component disassembly involved in execution phase of apoptosis [BP],
negative regulation of filopodium assembly [BP],
TIR domain binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_129_2 |
 |
 |
3 |
0.6 |
2.17E-04 |
ID1,
SKIL |
response to growth factor stimulus [BP],
response to antibiotic [BP] |
| CG_ffipsc1911_promoter_p_RM_12_191_8 |
 |
 |
3 |
0.6 |
3.67E-04 |
ARID1A,
ARID1B |
chromatin-mediated maintenance of transcription [BP],
SWI/SNF complex [CC] |
| CG_ffipsc1911_promoter_p_RM_14_1_7 |
 |
 |
8 |
1.0 |
4.34E-04 |
PNPLA2,
NOG,
HOXD11,
PNPLA3 |
triglyceride lipase activity [MF],
embryonic skeletal joint morphogenesis [BP],
acylglycerol acyl-chain remodeling [BP],
retinyl-palmitate esterase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_99_4 |
 |
 |
4 |
0.8 |
3.37E-04 |
SALL3,
NKX2-3 |
hindlimb morphogenesis [BP],
post-embryonic digestive tract morphogenesis [BP] |
| CG_ffipsc1911_promoter_p_RM_12_41_9 |
 |
 |
3 |
0.6 |
3.02E-04 |
DNAJB6,
TPM1,
CNTNAP1,
ANGPTL4,
VEGFA,
ADAM22,
IL32,
CD9,
PRKCA |
positive regulation of blood vessel endothelial cell migration [BP],
positive regulation of positive chemotaxis [BP],
positive regulation of ATPase activity [BP],
cell adhesion [BP],
induction of positive chemotaxis [BP],
positive regulation of angiogenesis [BP],
paranodal junction assembly [BP],
positive regulation of cell adhesion [BP],
macrophage differentiation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_115_6 |
 |
 |
6 |
1.0 |
1.98E-04 |
HHEX,
WNT10A,
PAX2,
CBX2,
GDF11,
FZD1 |
development of primary sexual characteristics [BP],
pancreas development [BP],
gonad development [BP],
female gonad development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_282_7 |
 |
 |
4 |
0.8 |
3.86E-04 |
NFATC1,
MOV10,
WRNIP1,
SH3BP4,
FYTTD1,
SLC30A9,
TBX4,
NDE1,
SPTBN1,
ARNTL,
BTG2,
DNAJB6,
GTF2I,
POU3F3,
RCN1,
NR4A1,
U2SURP,
VASP,
HEY2,
PKNOX1,
THAP3,
EIF2A,
ZBTB48,
BAIAP2,
MMP2,
AMOTL1 |
protein binding [MF],
mitogen-activated protein kinase binding [MF],
transcription factor complex [CC],
sequence-specific DNA binding transcription factor activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_25_10 |
 |
 |
2 |
0.4 |
2.75E-04 |
PDP2,
MDK |
magnesium-dependent protein serine/threonine phosphatase activity [MF],
[pyruvate dehydrogenase (lipoamide)] phosphatase activity [MF],
defecation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_273_5 |
 |
 |
4 |
0.6 |
1.72E-04 |
SLC11A1,
SMC3,
POU4F2,
MERTK,
ING2,
HHEX |
positive regulation of phagocytosis [BP],
chromatin binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_91_12 |
 |
 |
7 |
0.8 |
2.85E-04 |
MXI1,
TACC3,
NPAS2,
UTS2R |
cytoplasmic sequestering of transcription factor [BP],
circadian sleep/wake cycle [BP],
recycling endosome [CC] |
| CG_ffipsc1911_promoter_p_RM_12_109_4 |
 |
 |
4 |
0.8 |
3.61E-04 |
DUT,
SLC5A5,
PPP2R1A,
NT5M |
dUTP diphosphatase activity [MF],
sodium:iodide symporter activity [MF],
peptidyl-serine dephosphorylation [BP],
dUMP catabolic process [BP],
pyrimidine nucleobase metabolic process [BP],
dUMP biosynthetic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_194_3 |
 |
 |
2 |
0.4 |
5.68E-05 |
GATC,
CLYBL |
regulation of translational fidelity [BP],
citrate lyase complex [CC],
glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [MF],
citrate (pro-3S)-lyase activity [MF],
glutamyl-tRNA(Gln) amidotransferase complex [CC] |
| CG_ffipsc1911_promoter_p_RM_12_230_4 |
 |
 |
3 |
0.6 |
2.26E-04 |
KIAA1324,
TAB1,
GAB1,
RIPK1,
MGAT2,
IKZF1,
PPP2R1A |
activation of MAPK activity [BP],
alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF],
positive regulation of autophagic vacuole assembly [BP],
regulation of ATP:ADP antiporter activity [BP],
peptidyl-serine dephosphorylation [BP],
positive regulation of neutrophil differentiation [BP],
activation of JUN kinase activity [BP],
JNK cascade [BP],
positive regulation of vacuole organization [BP] |
| CG_ffipsc1911_promoter_p_RM_12_224_5 |
 |
 |
4 |
0.8 |
4.31E-04 |
HOOK3,
PHRF1,
SOX2 |
neuronal stem cell maintenance [BP],
RNA polymerase binding [MF] |
| CG_ffipsc1911_promoter_p_RM_14_39_2 |
 |
 |
3 |
0.4 |
1.19E-04 |
FGF2,
SDC2 |
substantia nigra development [BP],
glycosaminoglycan catabolic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_79_7 |
 |
 |
4 |
0.8 |
2.17E-04 |
HOXD8,
UHRF1,
FRS2,
ENTPD6 |
anterior/posterior axis specification, embryo [BP],
hemi-methylated DNA-binding [MF],
guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_238_4 |
 |
 |
6 |
1.0 |
4.00E-04 |
ADK,
NADSYN1,
NUDT16 |
dATP biosynthetic process [BP],
snoRNA catabolic process [BP],
adenosine kinase activity [MF],
ITP binding [MF],
XDP catabolic process [BP],
XTP binding [MF],
NAD+ synthase (glutamine-hydrolyzing) activity [MF],
dITP catabolic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_228_6 |
 |
 |
6 |
1.0 |
4.50E-04 |
RUNX2,
MOG,
SALL3,
POU3F3 |
central nervous system development [BP],
negative regulation of smoothened signaling pathway [BP] |
| CG_ffipsc1911_promoter_p_RM_12_170_5 |
 |
 |
5 |
1.0 |
2.06E-04 |
TM7SF2 |
delta14-sterol reductase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_190_12 |
 |
 |
6 |
0.8 |
4.65E-04 |
FSD1 |
microtubule organizing center [CC] |
| CG_ffipsc1911_promoter_p_RM_12_181_3 |
 |
 |
2 |
0.4 |
4.55E-04 |
CORO1A,
ADK,
UGP2,
TARBP2 |
UTP:glucose-1-phosphate uridylyltransferase activity [MF],
negative regulation of actin nucleation [BP],
dATP biosynthetic process [BP],
adenosine kinase activity [MF],
miRNA loading onto RISC involved in gene silencing by miRNA [BP] |
| CG_ffipsc1911_promoter_p_RM_14_21_2 |
 |
 |
1 |
0.2 |
2.62E-04 |
SLC25A26,
UTP20,
LARS2 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP],
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP],
S-adenosyl-L-methionine transport [BP],
S-adenosyl-L-methionine transmembrane transporter activity [MF],
leucyl-tRNA aminoacylation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_42_9 |
 |
 |
4 |
0.8 |
2.73E-04 |
ABCG1,
DNAJB6,
DSP,
PRKCA |
intermediate filament organization [BP],
detection of hormone stimulus [BP],
positive regulation of dense core granule biogenesis [BP],
desmosome organization [BP] |
| CG_ffipsc1911_promoter_p_RM_14_12_2 |
 |
 |
3 |
0.6 |
1.66E-04 |
SLC25A37,
INHBB |
negative regulation of hepatocyte growth factor biosynthetic process [BP],
host cell surface receptor binding [MF],
mitochondrial iron ion transport [BP] |
| CG_ffipsc1911_promoter_p_RM_12_187_4 |
 |
 |
4 |
0.6 |
3.15E-04 |
ID2,
HOXD11,
GABRA5,
ATF4,
FOXC1,
HINFP |
regulation of transcription involved in G1/S phase of mitotic cell cycle [BP],
gamma-aminobutyric acid signaling pathway [BP],
metanephros development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_71_14 |
 |
 |
5 |
1.0 |
2.15E-04 |
CCNK,
RTN3,
MDM2 |
response to stress [BP],
negative regulation of cell cycle arrest [BP] |
| CG_ffipsc1911_promoter_p_RM_14_3_4 |
 |
 |
5 |
0.6 |
4.98E-04 |
ROR1,
GRM3,
EPO |
transmembrane receptor protein tyrosine kinase activity [MF],
group II metabotropic glutamate receptor activity [MF],
erythropoietin receptor binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_69_5 |
 |
 |
3 |
0.6 |
2.48E-04 |
BLM,
LIG3,
IGF2BP1 |
negative regulation of DNA recombination [BP],
synaptonemal complex [CC],
regulation of cytokine biosynthetic process [BP],
ATPase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_110_5 |
 |
 |
5 |
0.8 |
2.14E-04 |
TRNT1,
DRD4 |
tRNA 3'-terminal CCA addition [BP],
ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [MF],
tRNA nucleotidyltransferase activity [MF],
olfactory learning [BP],
CTP:tRNA cytidylyltransferase activity [MF],
tRNA adenylyltransferase activity [MF],
CTP:3'-cytidine-tRNA cytidylyltransferase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_220_4 |
 |
 |
4 |
0.8 |
3.57E-04 |
LHX2,
LIAS,
PANX1 |
lipoate synthase activity [MF],
neural tube closure [BP],
leak channel activity [MF] |
| CG_ffipsc1911_promoter_p_RM_14_26_2 |
 |
 |
2 |
0.4 |
3.49E-04 |
TGIF1,
MEIS1,
ASF1A,
NIPBL |
chromatin binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_245_15 |
 |
 |
6 |
1.0 |
3.54E-04 |
GADD45B,
TGIF1,
DDX25,
HTRA2,
CYP26A1 |
multicellular organismal development [BP],
negative regulation of retinoic acid receptor signaling pathway [BP],
forebrain development [BP] |
| CG_ffipsc1911_promoter_p_RM_14_31_5 |
 |
 |
3 |
0.6 |
4.56E-04 |
MOCOS,
CNNM2 |
Mo-molybdopterin cofactor sulfurase activity [MF],
magnesium ion homeostasis [BP] |
| CG_ffipsc1911_promoter_p_RM_12_275_4 |
 |
 |
3 |
0.6 |
1.83E-04 |
CDKN1A,
GATA3,
ACER3 |
negative regulation of cell proliferation involved in mesonephros development [BP],
cyclin-dependent protein kinase activating kinase activity [MF],
phytosphingosine biosynthetic process [BP],
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP],
cellular response to ionizing radiation [BP],
regulation of histone H3-K27 methylation [BP],
phytoceramidase activity [MF],
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_105_5 |
 |
 |
7 |
1.0 |
2.14E-04 |
PSEN1,
GREM1,
LCK,
FOXC1,
TENC1 |
ureteric bud development [BP],
negative regulation of bone trabecula formation [BP],
kidney development [BP],
negative regulation of bone mineralization involved in bone maturation [BP],
Cajal-Retzius cell differentiation [BP],
peptidyl-tyrosine phosphorylation [BP],
collagen fibril organization [BP] |
| CG_ffipsc1911_promoter_p_RM_12_46_4 |
 |
 |
6 |
0.6 |
3.51E-04 |
UVRAG,
MTDH |
positive regulation of autophagy [BP] |
| CG_ffipsc1911_promoter_p_RM_14_28_1 |
 |
 |
4 |
0.6 |
2.91E-04 |
MAML1 |
MAML1-RBP-Jkappa- ICN1 complex [CC],
atrioventricular node cell development [BP],
atrioventricular node development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_206_5 |
 |
 |
7 |
1.0 |
4.96E-04 |
PTGFR |
prostaglandin F receptor activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_185_8 |
 |
 |
3 |
0.6 |
2.85E-04 |
SDC2,
KCNA5,
ADORA2A |
response to caffeine [BP],
positive regulation of apoptotic signaling pathway [BP],
membrane hyperpolarization [BP],
alpha-actinin binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_4_7 |
 |
 |
3 |
0.6 |
1.73E-04 |
HLA-F,
SOX8,
PIAS1,
VEGFA,
ICAM1,
TYRO3,
ANG |
ovarian follicle development [BP],
ovulation cycle [BP],
interferon-gamma-mediated signaling pathway [BP],
positive regulation of branching involved in ureteric bud morphogenesis [BP],
cell migration [BP] |
| CG_ffipsc1911_promoter_p_RM_12_147_6 |
 |
 |
5 |
0.8 |
4.01E-04 |
ZRANB1,
NELFB,
WHSC1,
LAMP5,
LMCD1,
CCND1,
TBX21,
MCM4,
ZNF576,
WWOX,
IGF2BP1,
ATF4,
HIST1H2BO,
HSF1 |
dendrite membrane [CC],
nucleus [CC] |
| CG_ffipsc1911_promoter_p_RM_12_125_4 |
 |
 |
3 |
0.6 |
2.85E-04 |
OPRL1,
WDYHV1 |
nociceptin receptor activity [MF],
protein-N-terminal glutamine amidohydrolase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_210_6 |
 |
 |
5 |
0.8 |
3.47E-04 |
AP3S1,
BLOC1S4 |
anterograde axon cargo transport [BP],
anterograde synaptic vesicle transport [BP] |
| CG_ffipsc1911_promoter_p_RM_12_40_5 |
 |
 |
4 |
0.8 |
2.07E-04 |
PRKCA,
CBX2,
TDRD3,
FOXL1,
BAIAP2,
TSC2,
ADK,
FOS |
positive regulation of cardiac muscle hypertrophy [BP],
methylated histone residue binding [MF],
cellular response to hormone stimulus [BP],
cartilage development [BP],
insulin receptor signaling pathway [BP],
regulation of insulin receptor signaling pathway [BP] |
| CG_ffipsc1911_promoter_p_RM_12_218_6 |
 |
 |
4 |
0.8 |
2.74E-04 |
GDF7,
FOXO3,
ACR,
PAX2,
FOXI2,
DUT,
PLK3 |
roof plate formation [BP],
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [BP],
vestibulocochlear nerve formation [BP],
optic chiasma development [BP],
positive regulation of optic nerve formation [BP],
initiation of primordial ovarian follicle growth [BP],
brain morphogenesis [BP],
acrosome matrix dispersal [BP],
positive regulation of tendon cell differentiation [BP],
pattern specification process [BP],
embryo development [BP],
dUMP biosynthetic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_82_8 |
 |
 |
2 |
0.4 |
1.24E-04 |
CHAF1B |
CAF-1 complex [CC],
DNA replication-dependent nucleosome assembly [BP] |
| CG_ffipsc1911_promoter_p_RM_12_268_12 |
 |
 |
5 |
1.0 |
3.19E-04 |
SOX12,
SLC25A27,
EPO |
reduction of mitochondrial calcium ion concentration [BP],
spinal cord development [BP],
erythropoietin receptor binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_5_6 |
 |
 |
5 |
1.0 |
3.62E-04 |
PPARD,
PTDSS2 |
linoleic acid binding [MF],
CDP-diacylglycerol-serine O-phosphatidyltransferase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_14_41_2 |
 |
 |
1 |
0.2 |
1.76E-04 |
PROX1,
HOXD3,
IL34 |
macrophage colony-stimulating factor receptor binding [MF],
positive regulation of neuron differentiation [BP],
positive regulation of G1/S transition checkpoint [BP],
positive regulation of forebrain neuron differentiation [BP],
DBD domain binding [MF],
hepatocyte cell migration [BP] |
| CG_ffipsc1911_promoter_p_RM_12_197_5 |
 |
 |
1 |
0.2 |
3.64E-05 |
ACSL3 |
positive regulation of Golgi to plasma membrane protein transport [BP],
positive regulation of phosphatidylcholine biosynthetic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_2_5 |
 |
 |
3 |
0.6 |
3.28E-04 |
CEBPB,
FOXL1,
BHLHE40 |
RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_77_11 |
 |
 |
5 |
0.8 |
3.30E-04 |
SMARCA2,
ENDOV,
VIM,
ZFPM2 |
endodeoxyribonuclease activity, producing 5'-phosphomonoesters [MF],
lens fiber cell development [BP],
RNA polymerase II transcription coactivator activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_55_8 |
 |
 |
4 |
0.8 |
3.78E-04 |
ZBTB16,
SPAST,
SMAD6,
POU4F2,
NR2F2,
SOX8,
SOX9,
ADAM22,
INA,
SYNM |
limb development [BP],
Sertoli cell development [BP],
positive regulation of chondrocyte differentiation [BP],
ureter morphogenesis [BP],
renal vesicle induction [BP],
positive regulation of kidney development [BP],
neurofilament cytoskeleton [CC],
astrocyte fate commitment [BP],
cell fate commitment [BP],
negative regulation of photoreceptor cell differentiation [BP],
positive regulation of branching involved in ureteric bud morphogenesis [BP],
nervous system development [BP],
transcription regulatory region DNA binding [MF],
central nervous system development [BP],
retina development in camera-type eye [BP],
negative regulation of myoblast differentiation [BP],
metanephric nephron tubule formation [BP],
ureteric bud development [BP],
retinal rod cell differentiation [BP],
negative regulation of transcription, DNA-dependent [BP],
Sertoli cell differentiation [BP],
positive regulation of cartilage development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_263_2 |
 |
 |
4 |
0.8 |
2.23E-04 |
P2RY1,
CD40,
ARNT2,
GATA4 |
A1 adenosine receptor binding [MF],
positive regulation of hormone secretion [BP],
positive regulation of transcription from RNA polymerase II promoter [BP],
signal transduction involved in regulation of gene expression [BP],
response to mechanical stimulus [BP],
ADP-activated nucleotide receptor activity [MF],
lung lobe formation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_167_10 |
 |
 |
4 |
0.8 |
4.63E-04 |
ZBTB10,
FUS,
CHD7,
LMNB1,
LHX9,
EPN1,
SNAP29,
LEMD3,
PAX7,
UTRN,
SOX11,
CCNF,
TMEM57,
ZC3H18,
SART1,
MAPKAPK3,
CDCA8,
ZNF451 |
nuclear inner membrane [CC],
nucleus [CC] |
| CG_ffipsc1911_promoter_p_RM_12_103_10 |
 |
 |
7 |
1.0 |
2.73E-04 |
DAND5,
MKL2,
CTHRC1,
VANGL2,
PROX1,
EPN1 |
ventricular septum morphogenesis [BP],
establishment of planar polarity involved in neural tube closure [BP],
Wnt receptor signaling pathway, planar cell polarity pathway [BP],
establishment of planar polarity [BP],
blood vessel morphogenesis [BP],
embryonic organ development [BP],
inner ear receptor stereocilium organization [BP],
ventricular septum development [BP],
cochlea morphogenesis [BP] |
| CG_ffipsc1911_promoter_p_RM_12_199_6 |
 |
 |
3 |
0.6 |
1.98E-04 |
SLC1A4 |
chloride transport [BP],
hydroxyproline transport [BP],
L-hydroxyproline transmembrane transporter activity [MF],
threonine transport [BP],
L-threonine transmembrane transporter activity [MF] |
| CG_ffipsc1911_promoter_p_RM_14_37_1 |
 |
 |
5 |
0.8 |
3.66E-04 |
KHK |
ketohexokinase activity [MF],
fructose catabolic process [BP] |
| CG_ffipsc1911_promoter_p_RM_14_9_10 |
 |
 |
7 |
1.0 |
4.57E-04 |
JAM3,
ZNF174,
MARVELD2,
SOX2,
ZNF559-ZNF177,
SCGB1A1,
MYO15A,
C12orf52 |
negative regulation of transcription from RNA polymerase II promoter [BP],
sensory perception of sound [BP],
Schmidt-Lanterman incisure [CC],
paranodal junction [CC] |
| CG_ffipsc1911_promoter_p_RM_12_182_6 |
 |
 |
3 |
0.6 |
4.30E-04 |
YWHAH,
IST1 |
glucocorticoid catabolic process [BP],
virus budding from nuclear membrane by viral capsid re-envelopment [BP] |
| CG_ffipsc1911_promoter_p_RM_12_285_6 |
 |
 |
1 |
0.2 |
2.64E-04 |
LMNB1,
LEMD3,
TEF,
SAP18,
CREBRF |
nuclear inner membrane [CC],
negative regulation of endoplasmic reticulum unfolded protein response [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_ffipsc1911_promoter_p_RM_14_33_4 |
 |
 |
3 |
0.4 |
4.63E-04 |
DNM2,
MACF1 |
post-Golgi vesicle-mediated transport [BP],
posttranslational protein targeting to membrane [BP],
microtubule binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_38_10 |
 |
 |
7 |
1.0 |
3.81E-04 |
IRF4,
ISL1 |
positive regulation of DNA binding [BP] |
| CG_ffipsc1911_promoter_p_RM_16_4_1 |
 |
 |
3 |
0.4 |
2.31E-04 |
LDLRAP1 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport [BP],
clathrin adaptor activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_113_8 |
 |
 |
6 |
1.0 |
2.37E-04 |
RNF17,
LTBP4,
NTRK2,
BMPR1A,
PVRL2,
POU2F3,
P2RX7,
CLIC6 |
dorsal/ventral axis specification [BP],
protein dimerization activity [MF],
neuronal cell body [CC],
response to fluid shear stress [BP],
transforming growth factor beta-activated receptor activity [MF],
protein homodimerization activity [MF],
transmembrane receptor protein serine/threonine kinase activity [MF],
positive regulation of T cell mediated cytotoxicity [BP] |
| CG_ffipsc1911_promoter_p_RM_12_193_6 |
 |
 |
4 |
0.8 |
2.38E-04 |
LHX2,
RBPJL,
TFAP2E,
YTHDC2,
NPAS1,
HABP4,
AR,
ZNF462,
ARID3A |
nucleic acid binding [MF],
positive regulation of transcription, DNA-dependent [BP],
sequence-specific DNA binding transcription factor activity [MF],
positive regulation of transcription from RNA polymerase II promoter [BP],
negative regulation of DNA binding [BP] |
| CG_ffipsc1911_promoter_p_RM_12_200_6 |
 |
 |
5 |
0.8 |
2.76E-04 |
SDC2,
NCS1,
AGAP3,
ZIC2,
NR2E1,
MAVS,
OGG1,
RARA |
regulation of protein import into nucleus, translocation [BP],
regulation of dendrite morphogenesis [BP],
chromatin DNA binding [MF],
positive regulation of IP-10 production [BP],
protein import into nucleus, translocation [BP],
amygdala development [BP],
Sertoli cell fate commitment [BP],
regulation of neuron projection development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_189_9 |
 |
 |
5 |
0.8 |
5.69E-05 |
IGHMBP2 |
ATP-dependent 5'-3' DNA helicase activity [MF],
ATP-dependent 5'-3' RNA helicase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_267_4 |
 |
 |
4 |
0.8 |
1.90E-04 |
GCDH |
glutaryl-CoA dehydrogenase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_51_6 |
 |
 |
5 |
0.8 |
2.55E-04 |
ENOPH1 |
acireductone synthase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_196_5 |
 |
 |
2 |
0.4 |
1.56E-04 |
BIRC5,
PNPLA3 |
mono-olein transacylation activity [MF],
interphase microtubule organizing center [CC],
diolein transacylation activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_171_7 |
 |
 |
3 |
0.6 |
2.10E-04 |
MAN1B1 |
endoplasmic reticulum quality control compartment [CC] |
| CG_ffipsc1911_promoter_p_RM_12_216_7 |
 |
 |
4 |
0.6 |
4.09E-04 |
KIF26B,
RAP1B,
GATA3 |
regulation of establishment of cell polarity [BP],
establishment of cell polarity [BP] |
| CG_ffipsc1911_promoter_p_RM_12_123_10 |
 |
 |
6 |
1.0 |
3.13E-04 |
UBE2B,
TOP1,
FOXF1,
EDNRA,
RBM38,
CTCF,
GPX4,
NEURL |
regulation of myotube differentiation [BP],
sperm axoneme assembly [BP],
chromosome segregation [BP],
in utero embryonic development [BP],
head development [BP],
multicellular organismal development [BP] |
| CG_ffipsc1911_promoter_p_RM_14_32_6 |
 |
 |
8 |
1.0 |
2.82E-04 |
POU4F3 |
vestibulocochlear nerve development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_265_5 |
 |
 |
2 |
0.4 |
3.97E-04 |
LPIN1,
CHAT |
phosphatidylcholine biosynthetic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_156_5 |
 |
 |
3 |
0.6 |
1.66E-04 |
UPB1 |
beta-ureidopropionase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_57_7 |
 |
 |
5 |
1.0 |
4.11E-04 |
COL13A1,
TLR2 |
collagen type XIII [CC],
chloramphenicol transport [BP],
triacyl lipopeptide binding [MF],
cell surface pattern recognition receptor signaling pathway [BP],
induction by symbiont of defense-related host nitric oxide production [BP] |
| CG_ffipsc1911_promoter_p_RM_12_253_5 |
 |
 |
4 |
0.8 |
3.16E-04 |
AGAP3,
OTUB1,
TOM1L1,
AGAP1 |
regulation of ARF GTPase activity [BP],
ubiquitin binding [MF],
ARF GTPase activator activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_286_7 |
 |
 |
5 |
1.0 |
3.75E-04 |
TPM4,
FERMT3 |
podosome [CC] |
| CG_ffipsc1911_promoter_p_RM_12_111_5 |
 |
 |
3 |
0.4 |
3.77E-04 |
SLIT2,
EIF3L |
negative regulation of lamellipodium assembly [BP],
negative regulation of mononuclear cell migration [BP],
negative regulation of smooth muscle cell chemotaxis [BP],
negative regulation of retinal ganglion cell axon guidance [BP],
induction of negative chemotaxis [BP],
negative regulation of neutrophil chemotaxis [BP],
corticospinal neuron axon guidance through spinal cord [BP],
fibrillar center [CC],
chemorepulsion involved in postnatal olfactory bulb interneuron migration [BP] |
| CG_ffipsc1911_promoter_p_RM_12_112_11 |
 |
 |
8 |
1.0 |
2.19E-04 |
MOG,
P2RY11,
GNAS,
FOXB1 |
cell migration in diencephalon [BP],
post-embryonic body morphogenesis [BP],
positive regulation of MyD88-dependent toll-like receptor signaling pathway [BP],
mammillary body development [BP],
activation of adenylate cyclase activity [BP],
inferior colliculus development [BP],
mammillothalamic axonal tract development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_43_8 |
 |
 |
5 |
0.8 |
2.79E-04 |
TRIM71,
ID2,
CUL4A,
PSMB9,
UHRF2,
WDR6 |
protein autoubiquitination [BP],
positive regulation of cell cycle arrest [BP],
cell cycle [BP],
cell cycle arrest [BP],
G1/S transition of mitotic cell cycle [BP],
nuclear heterochromatin [CC] |
| CG_ffipsc1911_promoter_p_RM_14_6_3 |
 |
 |
3 |
0.6 |
2.84E-04 |
MAP2K5,
PDPK1 |
3-phosphoinositide-dependent protein kinase activity [MF],
regulation of endothelial cell migration [BP],
negative regulation of chemokine (C-X-C motif) ligand 2 production [BP],
ERK5 cascade [BP] |
| CG_ffipsc1911_promoter_p_RM_12_126_4 |
 |
 |
4 |
0.8 |
2.60E-04 |
MTRR,
HMGCR |
[methionine synthase] reductase activity [MF],
NADP binding [MF],
hydroxymethylglutaryl-CoA reductase activity [MF],
hydroxymethylglutaryl-CoA reductase (NADPH) activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_270_6 |
 |
 |
6 |
1.0 |
3.79E-04 |
CHD7,
SOX2 |
nose development [BP],
genitalia development [BP],
detection of mechanical stimulus involved in equilibrioception [BP] |
| CG_ffipsc1911_promoter_p_RM_12_154_9 |
 |
 |
5 |
1.0 |
3.11E-04 |
PRKCA,
MADD,
AK4,
ARHGEF10 |
tetracycline metabolic process [BP],
positive regulation of GTP catabolic process [BP],
protein kinase activator activity [MF],
positive regulation of dense core granule biogenesis [BP],
carbon tetrachloride metabolic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_161_7 |
 |
 |
4 |
0.8 |
4.64E-04 |
ARID1A,
FOXF2,
YWHAH |
glucocorticoid receptor signaling pathway [BP],
genitalia development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_272_2 |
 |
 |
2 |
0.4 |
2.44E-04 |
ENTPD6 |
guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_16_2_1 |
 |
 |
2 |
0.4 |
7.34E-04 |
PCDHB11,
SPTBN4,
PCDHB14,
PCDHB12 |
axon hillock [CC],
homophilic cell adhesion [BP],
cell body fiber [CC],
synapse assembly [BP],
calcium ion binding [MF],
calcium-dependent cell-cell adhesion [BP],
transmission of nerve impulse [BP],
nervous system development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_13_3 |
 |
 |
1 |
0.2 |
1.93E-04 |
NDEL1,
PDPK1 |
3-phosphoinositide-dependent protein kinase activity [MF],
oligopeptidase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_279_4 |
 |
 |
3 |
0.6 |
3.04E-04 |
EIF3J,
MAPK4,
MNAT1 |
protein phosphorylation [BP],
cellular protein metabolic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_32_3 |
 |
 |
2 |
0.4 |
2.57E-04 |
TCEA2,
PROX1,
SUPT6H |
positive regulation of forebrain neuron differentiation [BP],
hepatocyte cell migration [BP],
DBD domain binding [MF],
regulation of DNA-dependent transcription, elongation [BP],
positive regulation of G1/S transition checkpoint [BP] |
| CG_ffipsc1911_promoter_p_RM_14_10_3 |
 |
 |
3 |
0.6 |
3.70E-04 |
AEBP1,
CAMK1D,
TALDO1,
AKAP5 |
sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF],
calmodulin binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_106_9 |
 |
 |
5 |
0.8 |
3.55E-04 |
VEGFA,
CD9,
CNTNAP1 |
paranodal junction assembly [BP],
lymph vessel morphogenesis [BP] |
| CG_ffipsc1911_promoter_p_RM_12_274_3 |
 |
 |
5 |
0.8 |
3.01E-04 |
ADM,
CDK5R1,
GRIN1 |
ionotropic glutamate receptor signaling pathway [BP],
adrenomedullin receptor binding [MF],
propylene metabolic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_213_7 |
 |
 |
4 |
0.6 |
3.23E-04 |
MTAP,
PAX2,
ENOPH1 |
metanephric epithelium development [BP],
L-methionine salvage from methylthioadenosine [BP],
polyamine metabolic process [BP] |
| CG_ffipsc1911_promoter_p_RM_14_34_10 |
 |
 |
8 |
1.0 |
2.74E-04 |
NTRK1 |
neurotrophin p75 receptor binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_260_4 |
 |
 |
5 |
0.8 |
3.32E-04 |
NT5M,
ADIPOQ,
SLC12A5 |
response to linoleic acid [BP],
detection of oxidative stress [BP],
negative regulation of metanephric mesenchymal cell migration [BP],
dUMP catabolic process [BP],
thermosensory behavior [BP],
positive regulation of renal albumin absorption [BP],
negative regulation of eukaryotic cell surface binding [BP],
positive regulation of metanephric glomerular visceral epithelial cell development [BP],
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [BP] |
| CG_ffipsc1911_promoter_p_RM_12_259_6 |
 |
 |
3 |
0.6 |
4.71E-04 |
MAEL,
DBF4B,
CENPW,
MYRF,
PBX3,
SRCAP |
anterior compartment pattern formation [BP],
DNA binding [MF],
nucleic acid binding [MF],
posterior compartment specification [BP] |
| CG_ffipsc1911_promoter_p_RM_12_271_17 |
 |
 |
7 |
0.8 |
3.86E-04 |
SMARCA5,
HPS6 |
nucleosome binding [MF],
organelle organization [BP] |
| CG_ffipsc1911_promoter_p_RM_12_152_4 |
 |
 |
4 |
0.8 |
2.69E-04 |
CAD,
GGPS1,
SQRDL |
aspartate binding [MF],
aspartate carbamoyltransferase activity [MF],
sulfide:quinone oxidoreductase activity [MF],
geranylgeranyl diphosphate biosynthetic process [BP],
carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [MF],
dihydroorotase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_14_36_5 |
 |
 |
7 |
0.8 |
3.11E-04 |
AAMDC,
PPARD,
ITPR3,
RYR1 |
positive regulation of fat cell differentiation [BP],
intracellular ligand-gated calcium channel activity [MF],
calcium-release channel activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_211_7 |
 |
 |
7 |
1.0 |
1.62E-04 |
ALPL,
HELT |
cementum mineralization [BP],
GABAergic neuron differentiation in basal ganglia [BP] |
| CG_ffipsc1911_promoter_p_RM_12_34_4 |
 |
 |
1 |
0.2 |
2.30E-04 |
DYRK2,
NUDT7,
NLRC5 |
negative regulation of type I interferon-mediated signaling pathway [BP],
acetyl-CoA catabolic process [BP],
manganese ion binding [MF],
coenzyme A catabolic process [BP] |
| CG_ffipsc1911_promoter_p_RM_12_131_10 |
 |
 |
5 |
1.0 |
4.70E-04 |
PRDX5,
FTL,
CYP4V2 |
regulation of apoptosis involved in tissue homeostasis [BP],
oxidoreductase activity [MF],
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [MF] |
| CG_ffipsc1911_promoter_p_RM_12_223_9 |
 |
 |
4 |
0.8 |
3.86E-04 |
IMPA2,
CDC7,
ESCO2 |
metal ion binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_276_5 |
 |
 |
3 |
0.6 |
3.30E-04 |
ADD1,
RCN1,
USP47,
GDF7,
FBXW8,
HERC5,
NIF3L1,
EDC4,
NOXA1,
NLK,
FOXC1,
ACP1,
PLXNC1 |
transcription factor binding [MF],
protein binding [MF],
negative regulation of mitotic cell cycle [BP],
in utero embryonic development [BP],
SCF ubiquitin ligase complex [CC] |
| CG_ffipsc1911_promoter_p_RM_12_52_13 |
 |
 |
7 |
1.0 |
2.23E-04 |
ITGB3,
BLOC1S4,
RYR2,
PROX1,
PKD2 |
intracellular ligand-gated calcium channel activity [MF],
tube development [BP],
spinal cord development [BP],
positive regulation of cyclin-dependent protein kinase activity [BP],
calcium-release channel activity [MF],
dorsal spinal cord development [BP],
platelet aggregation [BP],
calcium-induced calcium release activity [MF],
positive regulation of cell cycle [BP],
aorta development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_257_6 |
 |
 |
5 |
1.0 |
2.73E-04 |
MGME1 |
mitochondrial DNA repair [BP] |
| CG_ffipsc1911_promoter_p_RM_14_4_4 |
 |
 |
5 |
0.8 |
4.05E-04 |
BRSK1,
LRRK2,
ASF1A,
FOXG1,
HK1,
ID2,
NR2F2,
ARL4D,
STOX2,
DHX30,
WEE1,
HEY2,
PRDX5,
EIF3L |
maternal placenta development [BP],
negative regulation of transcription, DNA-dependent [BP],
negative regulation of DNA binding [BP],
radial pattern formation [BP],
regulation of cell cycle [BP],
placenta blood vessel development [BP],
positive regulation of transcription involved in G1/S phase of mitotic cell cycle [BP],
forebrain development [BP],
aging [BP],
neuron differentiation [BP],
protein binding [MF],
negative regulation of neural precursor cell proliferation [BP],
regulation of apoptosis involved in tissue homeostasis [BP],
negative regulation of gene expression [BP],
negative regulation of cardiac vascular smooth muscle cell differentiation [BP],
negative regulation of branching morphogenesis of a nerve [BP],
olfactory bulb development [BP] |
| CG_ffipsc1911_promoter_p_RM_14_8_6 |
 |
 |
3 |
0.4 |
3.57E-04 |
GPX4 |
phospholipid-hydroperoxide glutathione peroxidase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_114_10 |
 |
 |
4 |
0.6 |
1.71E-04 |
SMARCA2,
HOXC8 |
DNA-dependent ATPase activity [MF],
skeletal system morphogenesis [BP],
aortic smooth muscle cell differentiation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_20_13 |
 |
 |
4 |
0.6 |
2.68E-04 |
DIO3,
ADM |
hormone biosynthetic process [BP],
androgen metabolic process [BP],
endosome membrane [CC] |
| CG_ffipsc1911_promoter_p_RM_12_39_6 |
 |
 |
5 |
0.8 |
2.20E-04 |
PTGER4 |
negative regulation of eosinophil extravasation [BP],
negative regulation of integrin activation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_26_3 |
 |
 |
2 |
0.4 |
3.15E-04 |
GNAS |
mu-type opioid receptor binding [MF],
post-embryonic body morphogenesis [BP] |
| CG_ffipsc1911_promoter_p_RM_12_225_7 |
 |
 |
6 |
0.8 |
3.94E-04 |
SMG7,
PRDM13,
FAM120B,
TULP3,
POU4F2,
SECISBP2,
SOX2,
MYRF,
RPAIN,
ZBTB34,
ING2,
NEK7 |
nucleus [CC] |
| CG_ffipsc1911_promoter_p_RM_12_175_9 |
 |
 |
3 |
0.6 |
3.28E-04 |
SLC38A3 |
asparagine transport [BP],
histidine transport [BP],
L-asparagine transmembrane transporter activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_48_4 |
 |
 |
5 |
1.0 |
3.96E-04 |
CDK5R1,
NTRK2,
FMNL2 |
ephrin receptor binding [MF],
regulation of cell morphogenesis [BP] |
| CG_ffipsc1911_promoter_p_RM_12_217_5 |
 |
 |
6 |
1.0 |
3.99E-04 |
BMPR2,
MSX1 |
positive regulation of BMP signaling pathway [BP] |
| CG_ffipsc1911_promoter_p_RM_12_30_7 |
 |
 |
4 |
0.8 |
4.36E-04 |
NUDT1,
MOCS3 |
8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [MF],
DNA protection [BP],
dGTP catabolic process [BP],
URM1 activating enzyme activity [MF],
enzyme active site formation via L-cysteine persulfide [BP],
8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [MF],
thiosulfate sulfurtransferase activity [MF],
ATP diphosphatase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_177_7 |
 |
 |
6 |
1.0 |
4.18E-04 |
CREB1,
PRKAR1A |
activation of phospholipase C activity [BP] |
| CG_ffipsc1911_promoter_p_RM_16_8_1 |
 |
 |
2 |
0.4 |
2.92E-04 |
BLOC1S3 |
endosome to melanosome transport [BP] |
| CG_ffipsc1911_promoter_p_RM_12_242_5 |
 |
 |
5 |
0.8 |
4.43E-04 |
TOR1AIP1,
LMNB1 |
nuclear inner membrane [CC] |
| CG_ffipsc1911_promoter_p_RM_12_202_5 |
 |
 |
3 |
0.6 |
3.08E-04 |
STRA8,
SLC25A27 |
meiotic cell cycle DNA replication checkpoint [BP],
reduction of mitochondrial calcium ion concentration [BP] |
| CG_ffipsc1911_promoter_p_RM_12_122_9 |
 |
 |
6 |
1.0 |
4.12E-04 |
RPIA |
ribose-5-phosphate isomerase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_215_2 |
 |
 |
2 |
0.4 |
2.45E-04 |
FMN2 |
meiotic chromosome movement towards spindle pole [BP] |
| CG_ffipsc1911_promoter_p_RM_12_72_7 |
 |
 |
7 |
0.8 |
4.45E-04 |
NLGN1,
CACNG7 |
cytoskeletal matrix organization at active zone [BP],
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity [BP],
positive regulation of synaptic vesicle exocytosis [BP],
neurexin clustering [BP],
positive regulation of synaptic vesicle endocytosis [BP] |
| CG_ffipsc1911_promoter_p_RM_12_50_5 |
 |
 |
4 |
0.8 |
4.80E-04 |
WDR6,
GADD45B,
CABLES1,
ID2,
CUL4A |
regulation of cell cycle [BP],
cell cycle arrest [BP],
positive regulation of transcription involved in G1/S phase of mitotic cell cycle [BP] |
| CG_ffipsc1911_promoter_p_RM_12_203_3 |
 |
 |
5 |
1.0 |
1.14E-04 |
RPS6KA4,
NPL |
histone H3-S28 phosphorylation [BP],
histone H3-S10 phosphorylation [BP],
N-acetylneuraminate lyase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_65_7 |
 |
 |
7 |
0.8 |
2.45E-04 |
WDYHV1,
ADK,
L3MBTL1 |
SAM domain binding [MF],
protein-N-terminal glutamine amidohydrolase activity [MF],
dATP biosynthetic process [BP],
adenosine kinase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_23_3 |
 |
 |
4 |
0.8 |
2.29E-04 |
VLDLR,
ST3GAL3 |
N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF],
ventral spinal cord development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_266_5 |
 |
 |
3 |
0.6 |
2.80E-04 |
CIRBP,
PLEKHH1,
ADRB1,
KALRN |
response to cold [BP],
phospholipid binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_255_5 |
 |
 |
3 |
0.4 |
2.06E-04 |
FTSJD2,
FPGS,
DAND5,
FMN2,
EEF2K |
meiotic chromosome movement towards spindle pole [BP],
sequestering of nodal from receptor via nodal binding [BP],
tetrahydrofolylpolyglutamate synthase activity [MF],
mRNA methylation [BP],
elongation factor-2 kinase activity [MF],
mRNA (nucleoside-2'-O-)-methyltransferase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_16_5_1 |
 |
 |
2 |
0.4 |
6.74E-04 |
HIST3H2BB,
HIST1H2BO |
nucleosome assembly [BP],
nucleosome [CC],
protein heterodimerization activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_74_3 |
 |
 |
2 |
0.4 |
1.33E-04 |
PLK3,
CCND1 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [BP],
response to radiation [BP],
negative regulation of epithelial cell differentiation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_124_4 |
 |
 |
3 |
0.6 |
3.34E-04 |
GFER,
GLRX5,
GMPR2 |
purine-containing compound salvage [BP],
protein disulfide oxidoreductase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_130_4 |
 |
 |
3 |
0.6 |
2.96E-04 |
IDUA,
PLCG2 |
follicular B cell differentiation [BP],
L-iduronidase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_63_7 |
 |
 |
5 |
0.8 |
3.59E-04 |
ADHFE1,
PINK1 |
C3HC4-type RING finger domain binding [MF],
hydroxyacid-oxoacid transhydrogenase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_14_18_12 |
 |
 |
13 |
1.0 |
5.31E-04 |
SIRT1,
YY1,
POLE4,
EN2,
SOX11,
ZBTB18,
RCOR1,
REST,
SOX8,
HOXC12,
SKIL,
RNF111,
COL6A1,
FOXB2,
GMEB1,
LEMD3,
GATA3,
ARNT2,
PRDM16 |
protein heterotrimerization [BP],
histone deacetylation [BP],
nucleic acid binding transcription factor activity [MF],
white fat cell differentiation [BP],
core promoter binding [MF],
SMAD binding [MF],
transcriptional repressor complex [CC],
sequence-specific DNA binding transcription factor activity [MF],
response to growth factor stimulus [BP],
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF],
transcription regulatory region DNA binding [MF],
histone H4 deacetylation [BP],
negative regulation of cell differentiation [BP],
core promoter sequence-specific DNA binding [MF],
negative regulation of gene expression [BP],
regulation of transcription from RNA polymerase II promoter [BP],
negative regulation of transforming growth factor beta receptor signaling pathway [BP],
regulation of transforming growth factor beta receptor signaling pathway [BP],
RNA polymerase II core promoter sequence-specific DNA binding [MF],
sequence-specific DNA binding [MF],
negative regulation of transcription, DNA-dependent [BP],
protein deacetylation [BP],
transforming growth factor beta receptor signaling pathway [BP] |
| CG_ffipsc1911_promoter_p_RM_12_264_5 |
 |
 |
4 |
0.8 |
2.22E-04 |
CHAC1,
MDM2 |
negative regulation of protein processing [BP] |
| CG_ffipsc1911_promoter_p_RM_12_183_3 |
 |
 |
3 |
0.6 |
2.11E-04 |
SLC1A4 |
L-hydroxyproline transmembrane transporter activity [MF],
L-threonine transmembrane transporter activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_141_7 |
 |
 |
4 |
0.6 |
2.89E-04 |
DNAJC5,
SPR,
POR,
ATP1B3,
GMPS,
RAC1 |
pyrophosphatase activity [MF],
melanosome [CC],
GMP synthase (glutamine-hydrolyzing) activity [MF],
GMP synthase activity [MF],
iron-cytochrome-c reductase activity [MF],
NADP binding [MF],
sepiapterin reductase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_16_3_1 |
 |
 |
9 |
0.8 |
1.79E-04 |
AFMID,
CYP46A1 |
arylformamidase activity [MF],
cholesterol 24-hydroxylase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_176_3 |
 |
 |
6 |
1.0 |
2.99E-04 |
NAA60 |
N-terminal peptidyl-methionine acetylation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_250_9 |
 |
 |
4 |
0.8 |
4.12E-04 |
COPS4,
HSPA6 |
signalosome [CC] |
| CG_ffipsc1911_promoter_p_RM_12_166_4 |
 |
 |
2 |
0.4 |
3.84E-04 |
HOXD4,
WNT1,
NR2F1,
GATA4,
FGFR3,
HTRA2,
CDC73 |
Wnt receptor signaling pathway [BP],
epithelial cell fate commitment [BP],
stem cell differentiation [BP],
endoderm formation [BP],
forebrain development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_162_7 |
 |
 |
4 |
0.8 |
3.60E-04 |
ILK,
CMYA5 |
costamere [CC] |
| CG_ffipsc1911_promoter_p_RM_12_278_4 |
 |
 |
5 |
0.8 |
3.19E-04 |
GREM1,
ACAT1 |
negative regulation of bone mineralization involved in bone maturation [BP],
negative regulation of bone trabecula formation [BP],
metanephric proximal convoluted tubule development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_75_5 |
 |
 |
4 |
0.8 |
3.94E-04 |
RAB31,
AP1M1 |
trans-Golgi network membrane [CC] |
| CG_ffipsc1911_promoter_p_RM_12_15_11 |
 |
 |
5 |
1.0 |
3.43E-04 |
PSD2 |
neuron differentiation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_93_6 |
 |
 |
5 |
1.0 |
1.97E-04 |
FLVCR1,
FOXD3,
FOXF2,
FAS |
DNA binding, bending [MF],
spleen development [BP],
heme export [BP] |
| CG_ffipsc1911_promoter_p_RM_12_208_14 |
 |
 |
4 |
0.8 |
3.21E-04 |
RPS21,
RPS3 |
cytosolic small ribosomal subunit [CC] |
| CG_ffipsc1911_promoter_p_RM_12_132_3 |
 |
 |
3 |
0.6 |
3.11E-04 |
SWI5 |
Swi5-Sfr1 complex [CC] |
| CG_ffipsc1911_promoter_p_RM_12_155_6 |
 |
 |
4 |
0.8 |
1.87E-04 |
SPHK1,
NOS3,
SOX17,
TGFBI |
angiogenesis [BP],
cardiogenic plate morphogenesis [BP],
inner cell mass cellular morphogenesis [BP],
blood vessel development [BP],
sphingoid catabolic process [BP],
regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification [BP] |
| CG_ffipsc1911_promoter_p_RM_14_7_1 |
 |
 |
2 |
0.4 |
5.69E-04 |
UQCRH |
mitochondrial respiratory chain complex III [CC] |
| CG_ffipsc1911_promoter_p_RM_12_100_5 |
 |
 |
5 |
0.8 |
3.38E-04 |
RAD51,
SWSAP1 |
single-stranded DNA binding [MF],
positive regulation of DNA ligation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_140_11 |
 |
 |
6 |
0.8 |
4.08E-04 |
ID4,
NOG,
EIF5B,
USP15,
ATF5 |
negative regulation of astrocyte differentiation [BP],
pathway-restricted SMAD protein phosphorylation [BP],
gene expression [BP] |
| CG_ffipsc1911_promoter_p_RM_12_164_5 |
 |
 |
2 |
0.4 |
4.55E-04 |
MCM5,
CDC34,
WRN |
DNA replication [BP],
DNA replication initiation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_246_5 |
 |
 |
4 |
0.6 |
3.92E-04 |
ADAMTS15,
ECE2,
LNPEP |
metalloendopeptidase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_14_10 |
 |
 |
3 |
0.6 |
3.45E-04 |
YAP1,
MYC |
response to gamma radiation [BP],
transcription regulatory region DNA binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_277_5 |
 |
 |
1 |
0.2 |
2.80E-04 |
SOX17,
BLOC1S3,
PDK2,
ID1,
PI4K2A |
intrinsic apoptotic signaling pathway by p53 class mediator [BP],
BLOC-1 complex [CC],
protein destabilization [BP] |
| CG_ffipsc1911_promoter_p_RM_12_157_5 |
 |
 |
3 |
0.4 |
2.09E-04 |
P2RY1,
NEURL,
LHX2 |
telencephalon regionalization [BP],
brain development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_145_6 |
 |
 |
5 |
0.8 |
2.93E-04 |
HTT,
TARBP2 |
neural plate formation [BP],
diazepam binding [MF],
miRNA loading onto RISC involved in gene silencing by miRNA [BP] |
| CG_ffipsc1911_promoter_p_RM_12_10_6 |
 |
 |
3 |
0.6 |
2.58E-04 |
TNFRSF14,
DTX1,
SNX9 |
ubiquitin protein ligase binding [MF] |
| CG_ffipsc1911_promoter_p_RM_14_40_2 |
 |
 |
5 |
0.8 |
4.90E-04 |
BHLHE40,
FAM20B,
LSM11,
RIPK1,
PLK1,
SBK1,
SQSTM1 |
regulation of ATP:ADP antiporter activity [BP],
protein serine/threonine kinase activity [MF],
protein kinase activity [MF],
phosphotransferase activity, alcohol group as acceptor [MF],
kinase activity [MF],
protein heterooligomerization [BP],
U7 snRNA binding [MF],
transcription from RNA polymerase II promoter [BP] |
| CG_ffipsc1911_promoter_p_RM_16_7_3 |
 |
 |
9 |
1.0 |
6.41E-04 |
POU3F2,
SIRT1,
POLE4,
ARID1A,
ZBTB18,
SOX8,
DYRK2,
GATA3,
PRDM16 |
transcription coactivator activity [MF],
nuclear chromosome [CC],
RNA polymerase II core promoter sequence-specific DNA binding [MF],
fat cell differentiation [BP],
sequence-specific DNA binding [MF],
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [BP],
white fat cell differentiation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_37_8 |
 |
 |
4 |
0.8 |
2.70E-04 |
TYMS,
POU3F3,
TARDBP,
FOXO3 |
metanephric macula densa development [BP],
dTMP biosynthetic process [BP],
initiation of primordial ovarian follicle growth [BP],
immortalization of host cell by virus [BP],
thymidylate synthase activity [MF],
tissue development [BP],
transcription from RNA polymerase II promoter [BP] |
| CG_ffipsc1911_promoter_p_RM_14_5_2 |
 |
 |
2 |
0.4 |
6.25E-04 |
AGBL5 |
protein branching point deglutamylation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_243_9 |
 |
 |
5 |
0.6 |
4.14E-04 |
USF2,
FPGS,
GAPDH,
CCND1 |
peptidyl-cysteine S-nitrosylase activity [MF],
tetrahydrofolylpolyglutamate synthase activity [MF],
peptidyl-cysteine S-trans-nitrosylation [BP],
lactation [BP],
organ regeneration [BP] |
| CG_ffipsc1911_promoter_p_RM_12_97_4 |
 |
 |
4 |
0.8 |
1.39E-04 |
THBS1,
MDH1 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [BP],
diiodophenylpyruvate reductase activity [MF],
negative regulation of cGMP-mediated signaling [BP],
negative regulation of nitric oxide mediated signal transduction [BP],
positive regulation of eukaryotic cell surface binding [BP],
negative regulation of dendritic cell antigen processing and presentation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_136_4 |
 |
 |
2 |
0.4 |
4.15E-04 |
GPT |
L-alanine:2-oxoglutarate aminotransferase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_44_12 |
 |
 |
7 |
1.0 |
3.63E-04 |
WDR6,
ID2,
UHRF2,
TRIM71,
CUL4A |
protein autoubiquitination [BP],
olfactory bulb development [BP],
cell cycle arrest [BP],
nuclear heterochromatin [CC] |
| CG_ffipsc1911_promoter_p_RM_12_31_6 |
 |
 |
4 |
0.8 |
8.87E-05 |
MPST,
USB1,
GATA4 |
lung lobe formation [BP],
U6 snRNA 3'-end processing [BP],
3-mercaptopyruvate sulfurtransferase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_14_23_2 |
 |
 |
3 |
0.4 |
4.55E-04 |
TRIM71,
ACTN4,
UBC,
VEGFA,
SLC22A3,
PPCDC |
regulation of transcription from RNA polymerase II promoter in response to hypoxia [BP],
basophil chemotaxis [BP],
histamine uptake [BP],
response to hypoxia [BP],
hypothalamus gonadotrophin-releasing hormone neuron development [BP],
platelet alpha granule lumen [CC],
phosphopantothenoylcysteine decarboxylase activity [MF],
regulation of neural precursor cell proliferation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_107_3 |
 |
 |
8 |
1.0 |
3.51E-04 |
PTF1A,
INHBB,
GATA4,
FOXL1,
AACS |
ovarian follicle development [BP],
retinoic acid receptor signaling pathway [BP],
visceral mesoderm-endoderm interaction involved in midgut development [BP],
response to starvation [BP],
negative regulation of hepatocyte growth factor biosynthetic process [BP],
lung lobe formation [BP] |
| CG_ffipsc1911_promoter_p_RM_14_16_3 |
 |
 |
4 |
0.6 |
4.41E-04 |
SLC5A2 |
low-affinity glucose:sodium symporter activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_134_6 |
 |
 |
3 |
0.4 |
3.22E-04 |
FOXC1,
SMAD6 |
ureteric bud development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_12_3 |
 |
 |
3 |
0.6 |
2.07E-04 |
FPGS,
PCYOX1 |
tetrahydrofolylpolyglutamate synthase activity [MF],
prenylcysteine oxidase activity [MF],
chloride-transporting ATPase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_160_3 |
 |
 |
3 |
0.6 |
2.93E-04 |
APC2,
TPM1,
TUBG1 |
positive regulation of heart rate by epinephrine [BP],
microtubule cytoskeleton organization [BP],
actin filament [CC] |
| CG_ffipsc1911_promoter_p_RM_12_95_4 |
 |
 |
3 |
0.6 |
2.64E-04 |
CYR61,
MAT2B,
KATNB1 |
dTDP-4-dehydrorhamnose reductase activity [MF],
katanin complex [CC],
intussusceptive angiogenesis [BP],
methionine adenosyltransferase complex [CC],
extracellular polysaccharide biosynthetic process [BP],
methionine adenosyltransferase regulator activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_83_7 |
 |
 |
6 |
1.0 |
2.10E-04 |
CARM1,
PARK7 |
negative regulation of protein binding [BP] |
| CG_ffipsc1911_promoter_p_RM_14_25_2 |
 |
 |
3 |
0.4 |
2.43E-04 |
HHEX,
AACS |
liver development [BP],
acetoacetate-CoA ligase activity [MF],
hepatic duct development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_159_5 |
 |
 |
3 |
0.6 |
4.10E-04 |
NR2F2,
VIL1 |
cytoplasmic actin-based contraction involved in cell motility [BP],
radial pattern formation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_209_7 |
 |
 |
5 |
0.8 |
3.47E-04 |
NOG,
PARD6B,
ORAI1,
YAP1,
TES |
notochord development [BP],
somatic stem cell maintenance [BP],
protein complex [CC] |
| CG_ffipsc1911_promoter_p_RM_14_11_4 |
 |
 |
5 |
0.6 |
1.82E-04 |
PTH1R |
parathyroid hormone receptor activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_149_4 |
 |
 |
4 |
0.8 |
3.81E-04 |
BGLAP,
TET2,
EPO,
CLP1 |
myeloid cell differentiation [BP],
ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [MF],
siRNA loading onto RISC involved in RNA interference [BP],
response to testosterone stimulus [BP] |
| CG_ffipsc1911_promoter_p_RM_12_244_7 |
 |
 |
4 |
0.8 |
2.59E-04 |
FZD6,
PROX1 |
negative regulation of sequence-specific DNA binding transcription factor activity [BP] |
| CG_ffipsc1911_promoter_p_RM_12_121_4 |
 |
 |
5 |
1.0 |
3.82E-04 |
CLTA,
AP2M1 |
clathrin coat of coated pit [CC],
clathrin-coated endocytic vesicle membrane [CC] |
| CG_ffipsc1911_promoter_p_RM_12_128_7 |
 |
 |
4 |
0.6 |
1.69E-04 |
GATA4,
KCNA5,
NAT8L,
VANGL2,
AMDHD1 |
imidazolonepropionase activity [MF],
aspartate N-acetyltransferase activity [MF],
heart looping [BP],
voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [MF],
lung lobe formation [BP],
ventricular septum development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_248_7 |
 |
 |
3 |
0.6 |
2.18E-04 |
MPHOSPH8,
NFKBIB,
SMAD6,
ZNF783,
SIM2,
PIAS4,
RAI1,
PKNOX1,
BRD2,
LMCD1 |
transcription, DNA-dependent [BP],
transcription from RNA polymerase II promoter [BP],
regulation of transcription, DNA-dependent [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_ffipsc1911_promoter_p_RM_12_281_5 |
 |
 |
4 |
0.6 |
2.89E-04 |
SMCHD1,
GIGYF2,
POLR2M |
spinal cord motor neuron differentiation [BP],
maintenance of ER location [BP],
inactivation of X chromosome by DNA methylation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_8_8 |
 |
 |
5 |
1.0 |
1.37E-04 |
RPS6KA1,
SOX11,
RBPJ,
NPAS4,
JDP2,
ITGA6,
HOXD3,
POGLUT1,
ZSCAN20,
ARID3A |
positive regulation of transcription, DNA-dependent [BP],
Notch signaling pathway [BP],
sequence-specific DNA binding transcription factor activity [MF],
positive regulation of BMP signaling pathway [BP],
positive regulation of transcription from RNA polymerase II promoter [BP],
nucleic acid binding transcription factor activity [MF],
positive regulation of gene expression [BP] |
| CG_ffipsc1911_promoter_p_RM_12_287_6 |
 |
 |
4 |
0.8 |
3.03E-04 |
POU3F3 |
metanephric macula densa development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_198_10 |
 |
 |
6 |
1.0 |
3.59E-04 |
MTAP |
S-methyl-5-thioadenosine phosphorylase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_22_7 |
 |
 |
4 |
0.8 |
1.46E-04 |
MGST1,
SDHAF2 |
protein-FAD linkage [BP],
cellular response to lipid hydroperoxide [BP] |
| CG_ffipsc1911_promoter_p_RM_12_226_5 |
 |
 |
3 |
0.6 |
3.29E-04 |
ENO3,
ENO2 |
phosphopyruvate hydratase activity [MF],
phosphopyruvate hydratase complex [CC] |
| CG_ffipsc1911_promoter_p_RM_14_38_3 |
 |
 |
3 |
0.6 |
2.66E-04 |
ICAM1 |
response to sulfur dioxide [BP],
T cell antigen processing and presentation [BP],
cell adhesion mediated by integrin [BP] |
| CG_ffipsc1911_promoter_p_RM_12_153_10 |
 |
 |
4 |
0.6 |
5.81E-05 |
SNX9 |
lipid tube assembly [BP] |
| CG_ffipsc1911_promoter_p_RM_16_9_1 |
 |
 |
1 |
0.2 |
5.08E-05 |
ZNF808,
ZNF701,
ZNF761,
ZNF845,
ZNF765 |
transcription, DNA-dependent [BP],
DNA binding [MF],
regulation of transcription, DNA-dependent [BP],
zinc ion binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_283_8 |
 |
 |
5 |
1.0 |
3.01E-04 |
EPO,
SOX12,
CDK1,
PPARD,
PAX2,
EXOSC2,
TYMS |
aging [BP],
regulation of transcription involved in G1/S phase of mitotic cell cycle [BP],
exosome (RNase complex) [CC],
response to vitamin A [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_ffipsc1911_promoter_p_RM_14_14_2 |
 |
 |
2 |
0.4 |
3.05E-04 |
PRDX5,
CNTN2 |
positive regulation of adenosine receptor signaling pathway [BP],
regulation of apoptosis involved in tissue homeostasis [BP],
establishment of protein localization to juxtaparanode region of axon [BP],
peroxynitrite reductase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_254_9 |
 |
 |
4 |
0.8 |
3.64E-04 |
PAFAH1B1,
ID4 |
astral microtubule [CC],
cerebral cortex neuron differentiation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_21_3 |
 |
 |
2 |
0.4 |
2.07E-04 |
GPD2,
GPX4,
NEK8,
PAX2,
DIO3 |
sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [MF],
vestibulocochlear nerve formation [BP],
positive regulation of optic nerve formation [BP],
optic chiasma development [BP],
thyroxine 5-deiodinase activity [MF],
cytoskeleton [CC],
phospholipid-hydroperoxide glutathione peroxidase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_14_19_3 |
 |
 |
3 |
0.4 |
3.91E-04 |
LHX9,
WNT1,
CNTN2,
ID4,
PPCS,
SLC12A5 |
cerebral cortex neuron differentiation [BP],
positive regulation of adenosine receptor signaling pathway [BP],
central nervous system myelination [BP],
phosphopantothenate--cysteine ligase activity [MF],
negative regulation of neuron differentiation [BP],
midbrain-hindbrain boundary maturation during brain development [BP],
thermosensory behavior [BP],
negative regulation of DNA damage checkpoint [BP],
cerebellum formation [BP],
gonad morphogenesis [BP],
negative regulation of fat cell differentiation [BP],
establishment of protein localization to juxtaparanode region of axon [BP],
regulation of astrocyte differentiation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_251_8 |
 |
 |
5 |
0.8 |
1.83E-04 |
CTR9,
GAB1,
RNF40,
MKRN2 |
histone H2B ubiquitination [BP],
ligase activity [MF],
interleukin-6-mediated signaling pathway [BP],
histone monoubiquitination [BP] |
| CG_ffipsc1911_promoter_p_RM_12_89_9 |
 |
 |
5 |
0.8 |
2.89E-04 |
HEY2,
LHX2 |
negative regulation of transcription regulatory region DNA binding [BP] |
| CG_ffipsc1911_promoter_p_RM_12_70_5 |
 |
 |
3 |
0.6 |
2.62E-04 |
HDAC1,
MARS,
STUB1 |
positive regulation of chaperone-mediated protein complex assembly [BP],
fungiform papilla formation [BP],
methionyl-tRNA aminoacylation [BP],
methionine-tRNA ligase activity [MF],
transforming growth factor beta receptor signaling pathway [BP] |
| CG_ffipsc1911_promoter_p_RM_12_178_5 |
 |
 |
1 |
0.2 |
4.53E-04 |
TOP1 |
replication fork protection complex [CC] |
| CG_ffipsc1911_promoter_p_RM_12_49_5 |
 |
 |
5 |
1.0 |
1.35E-04 |
BMPR1B,
BMP6 |
positive regulation of bone mineralization [BP] |
| CG_ffipsc1911_promoter_p_RM_12_29_6 |
 |
 |
4 |
0.8 |
3.63E-04 |
IKZF1,
GPI,
CTDP1,
SLC2A4 |
positive regulation of neutrophil differentiation [BP],
amylopectin biosynthetic process [BP],
transcription from RNA polymerase II promoter [BP],
methylglyoxal biosynthetic process [BP],
glucose-6-phosphate isomerase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_239_6 |
 |
 |
2 |
0.4 |
2.59E-04 |
ARF1 |
cellular membrane organization [BP] |
| CG_ffipsc1911_promoter_p_RM_12_108_8 |
 |
 |
8 |
1.0 |
2.83E-04 |
RPL37A,
AP2A1,
PROX1,
IDUA,
SIVA1 |
CD27 receptor binding [MF],
L-iduronidase activity [MF],
positive regulation of G1/S transition checkpoint [BP],
positive regulation of forebrain neuron differentiation [BP],
DBD domain binding [MF],
hepatocyte cell migration [BP],
viral reproduction [BP] |
| CG_ffipsc1911_promoter_p_RM_12_139_4 |
 |
 |
2 |
0.4 |
1.95E-04 |
FAHD1,
USP3,
PDIA2,
USP15,
KDELR3 |
protein retention in ER lumen [BP],
ubiquitin-specific protease activity [MF],
fumarylpyruvate hydrolase activity [MF],
acylpyruvate hydrolase activity [MF],
acetylpyruvate hydrolase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_35_5 |
 |
 |
3 |
0.6 |
3.36E-04 |
LMX1B,
NKD1 |
positive regulation of non-canonical Wnt receptor signaling pathway via JNK cascade [BP],
neuron differentiation [BP],
negative regulation of convergent extension involved in axis elongation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_118_4 |
 |
 |
3 |
0.6 |
1.51E-04 |
PFAS |
phosphoribosylformylglycinamidine synthase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_92_8 |
 |
 |
4 |
0.6 |
2.82E-04 |
FOXL1,
SALL3,
KIAA1244,
ACVR2A |
forelimb morphogenesis [BP],
regulation of ARF protein signal transduction [BP],
embryonic skeletal system development [BP] |
| CG_ffipsc1911_promoter_p_RM_12_249_6 |
 |
 |
4 |
0.8 |
5.08E-04 |
ADHFE1 |
hydroxyacid-oxoacid transhydrogenase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_144_2 |
 |
 |
4 |
0.8 |
3.38E-04 |
CROT |
carnitine O-octanoyltransferase activity [MF] |
| CG_ffipsc1911_promoter_p_RM_12_133_5 |
 |
 |
5 |
0.8 |
4.07E-04 |
DAO |
cofactor binding [MF] |
| CG_ffipsc1911_promoter_p_RM_12_60_4 |
 |
 |
2 |
0.4 |
1.73E-04 |
TGM4 |
protein polyamination [BP] |
| CG_ffipsc1911_promoter_p_RM_12_3_5 |
 |
 |
4 |
0.8 |
2.37E-04 |
AATF,
ZYX,
PDPK1 |
focal adhesion [CC] |
| CG_ffipsc1911_promoter_p_RM_12_142_4 |
 |
 |
2 |
0.4 |
2.26E-04 |
SUPT5H,
SKI,
PIAS4,
ISL1,
NR2F1 |
negative regulation of transcription from RNA polymerase II promoter [BP],
positive regulation of DNA binding [BP] |
| CG_ffipsc1911_promoter_p_RM_12_247_9 |
 |
 |
6 |
1.0 |
3.46E-04 |
GDF7,
MAP3K4,
PPARD,
CREB3L4,
HLF,
HEY2,
ISL2 |
roof plate formation [BP],
negative regulation of cardiac vascular smooth muscle cell differentiation [BP],
sequence-specific DNA binding [MF],
placenta development [BP],
positive regulation of tendon cell differentiation [BP],
cell fate commitment [BP] |
| CG_ffipsc1911_promoter_p_RM_12_11_6 |
 |
 |
4 |
0.8 |
1.14E-04 |
NAGS,
RFX6 |
acetyl-CoA:L-glutamate N-acetyltransferase activity [MF],
pancreatic D cell differentiation [BP],
pancreatic epsilon cell differentiation [BP] |
| CG_ffipsc1911_promoter_p_RM_12_47_5 |
 |
 |
4 |
0.6 |
2.83E-04 |
SLC35A1,
CNTN2 |
positive regulation of adenosine receptor signaling pathway [BP],
CMP-N-acetylneuraminate transport [BP],
CMP-N-acetylneuraminate transmembrane transporter activity [MF],
establishment of protein localization to juxtaparanode region of axon [BP] |
| CG_ffipsc1911_promoter_p_RM_12_59_7 |
 |
 |
6 |
1.0 |
2.18E-04 |
CCND2,
CCND1 |
cyclin-dependent protein kinase holoenzyme complex [CC],
positive regulation of cyclin-dependent protein kinase activity [BP] |
| CG_ffipsc1911_promoter_p_RM_12_81_12 |
 |
 |
7 |
1.0 |
3.67E-04 |
UNK |
nucleic acid binding [MF] |